Carbidopa and Zometa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carbidopa (carbidopa) and Zometa (zoledronic acid). Common drug interactions include lung infiltration among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Carbidopa and Zometa. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Carbidopa?

Carbidopa has active ingredients of carbidopa. It is often used in parkinson's disease. eHealthMe is studying from 3,061 Carbidopa users. Check the latest studies of Carbidopa.

What is Zometa?

Zometa has active ingredients of zoledronic acid. It is often used in multiple myeloma. eHealthMe is studying from 71,434 Zometa users. Check the latest studies of Zometa.

On Aug, 12, 2026

19 people who take Carbidopa and Zometa together, and have interactions are studied.

What are the common drug interactions of Carbidopa and Zometa, by gender? *:

female:

Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Macule (a discoloured spot on the skin)
Malignant neoplasm progression (cancer tumour came back)
Metastases to bone (cancer spreads to bone)
Mitral valve sclerosis (thickening and stiffness of the valve)
Monoclonal immunoglobulin present
Mood swings (an extreme or rapid change in mood)
Mouth ulceration (mouth ulcers)
Muscle spasms (muscle contraction)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)

male:

Fatigue (feeling of tiredness)
Balance disorder
Colon cancer metastatic (cancer of colon spreads to other part of body)
Dermatitis diaper (diaper rash is a common form of inflamed skin)
Insomnia (sleeplessness)
Pneumonia
Skin irritation
Urticaria (rash of round, red welts on the skin that itch intensely)
Confusional state
Dehydration (dryness resulting from the removal of water)

What are the common drug interactions of Carbidopa and Zometa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Neuropathy peripheral (surface nerve damage)
Abdominal pain
Cataract (clouding of the lens inside the eye)
Dyspnoea (difficult or laboured respiration)
Intervertebral disc degeneration (spinal disc degeneration)
Osteomyelitis (infection of bone)
Osteonecrosis of jaw (death of bone of jaw)
Osteoporosis (bones weak and more likely to break)
Pain
Pain in jaw

What are the existing conditions these people have? *

Prostate Cancer: 6 people, 31.58%
Pain: 3 people, 15.79%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 3 people, 15.79%
Upper Respiratory Tract Infection: 2 people, 10.53%
Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 10.53%
Muscle Spasms (muscle contraction): 2 people, 10.53%
Precancerous Skin Lesion: 1 person, 5.26%
Polycythaemia (proportion of blood volume that is occupied by red blood cells increases): 1 person, 5.26%
Diabetes: 1 person, 5.26%
Breast Cancer: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Carbidopa and Zometa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously